Brian Sheridan
Partner, Archimed Private Equity, Former General Counsel, Chief Compliance Officer and Company Secretary, LivaNova PLC (Milan, London)
Brian Sheridan is a Partner in Private Equity Firm Archimed, a fund fully dedicated to the healthcare sector. Brian was formerly General Counsel, Chief Compliance Officer and Company Secretary at LivaNova PLC, listed on the LSE and NASDAQ, formed from the 2015 merger of Sorin S.p.A. and Cyberonics Inc. Brian led the Transaction Team for this deal, involving simultaneous and highly complex cross-border de-listings, merger and re-listings, and more recently the Transaction Team for the pan-jurisdictional carve-out divestiture of the Cardiac Rhythm Management Division to Chinese acquirors. Brian and his team have won numerous awards for their M&A activities, as well as litigation, and business ethics awards. Prior to joining Sorin S.p.A. Brian was a Partner in Oppenheimer. Wolff & Donnelly LLP.